Clinical trial
Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes
NCT01869881 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes
- Lead sponsor
- Yuhan Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 1, 2013
- Completion date
- January 28, 2015
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy